Have a personal or library account? Click to login
A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis Cover

A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis

Romanian Journal of Internal Medicine
Volume 55 (2017): Issue 3 (September 2017)
By: Hirokazu Yamagami,  Yu Nishida,  Yasuaki Nagami,  Shuhei Hosomi,  Tomomi Yukawa,  Koji Otani,  Fumio Tanaka,  Koichi Taira,  Noriko Kamata,  Tetsuya Tanigawa,  Masatsugu Shiba,  Toshio Watanabe and  Yasuhiro Fujiwara  
Open Access
|Aug 2017

Authors

Hirokazu Yamagami

yamagami@med.osaka-cu.ac.jp

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Yu Nishida

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Yasuaki Nagami

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Shuhei Hosomi

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Tomomi Yukawa

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Koji Otani

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Fumio Tanaka

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Koichi Taira

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Noriko Kamata

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Tetsuya Tanigawa

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Masatsugu Shiba

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Toshio Watanabe

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan

Yasuhiro Fujiwara

Department of Gastroenterology, Osaka City University Graduate School of Medicine 1-4-3, Asahimachi, Abeno-ku,, Osaka, Japan
DOI: https://doi.org/10.1515/rjim-2017-0012 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 151 - 157
Submitted on: Jan 25, 2017
Published on: Aug 19, 2017
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
infliximab,
inverse probability of treatment weighting,
remission rate,
tacrolimus,
ulcerative colitis
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2017 Hirokazu Yamagami, Yu Nishida, Yasuaki Nagami, Shuhei Hosomi, Tomomi Yukawa, Koji Otani, Fumio Tanaka, Koichi Taira, Noriko Kamata, Tetsuya Tanigawa, Masatsugu Shiba, Toshio Watanabe, Yasuhiro Fujiwara, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 55 (2017): Issue 3 (September 2017)Next article